Head-to-head · WeighScore
Edessa vs NEUVÉ Health
By GLP-1 ScorecardUpdated
Score comparison
Edessa has the higher recorded score — 70.8/100 to 64.7/100.
Edessa grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Clean three-rung tables one click in, behind a homepage whose three cards all quote six-month rungs and whose cheapest belongs to a different drug.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Edessa | NEUVÉ Health |
|---|---|---|
| WeighScore | 70.8/100 | 64.7/100 |
| Grade | C | C |
| Site position | #112 | #260 |
| Semaglutide | $179/mo month-to-month injectable ($135 only on a 6-month prepay) | $179/mo (injectable microdose with B12; the site gives three answers on whether medication is included) |
| Tirzepatide | $239/mo month-to-month ($209 only on a 6-month prepay) | $240/mo (injectable microdose with B12; the site gives three answers on whether medication is included) |
| Coverage | Not publicly listed | All 50 states (claimed; the same page says members in 40+ states) |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #112 · C
Strengths
- Each product page carries a plain three-rung table, so the commitment behind every figure is visible
- "Same price, every dose" is printed on each product page
- Names its operating entity and a full street address in Las Vegas, Nevada
- All-inclusive: provider consultation, medication, free expedited shipping, ongoing check-ins and 24/7 clinical support, and HSA and FSA eligible
- An oral tablet sits beside the two injections
What to consider
- The homepage leads with "Start for just $135", a six-month prepay on the semaglutide injection; month-to-month tirzepatide is $239
- All three homepage cards quote the six-month rung, so the real monthly rates appear only after a click
- Its Terms give two corporate forms for the same company in one clause — "Edessa Group, LLC, a Nevada corporation"
- "Join 100,000+ successful GLP-1 patients" carries no source, and the money-back guarantee's terms are on no marketing page
- No lab or monitoring protocol is published
Site position #260 · C
Strengths
- The whole GLP-1 catalog is built around microdosing rather than offering it as an afterthought, with an injectable and a daily sublingual route at different prices
- Names its lab partners, Quest and LabCorp, and says panel pricing is confirmed before a charge
- States both compounding classes on the homepage rather than leaving the question open
- Names clinicians on the site and inside the matching step of the intake
- A large hormone, peptide and lab menu sits beside the GLP-1 lines
What to consider
- Three incompatible answers to whether medication is in the price: the weight-loss program page is headed “all-in monthly pricing” and its own fine print says medication, labs and supplies are billed separately
- Four different “from” floors are published across four pages, one of which belongs to the testosterone line rather than the GLP-1 one
- Three membership tiers — Core, Plus and Premium — are named once in the financial policy and priced nowhere
- The tirzepatide sublingual microdose card lists compounded sublingual semaglutide microdose in its own inclusion list
- Every legal page closes by saying it is plain-English summary copy under review by counsel and may change before public launch, on a site already taking intake
- “All 50 U.S. states” and “members in 40+ states” are printed on the same homepage without the distinction the About page draws
- Membership fees are non-refundable, and no pharmacy, medical group entity or NPI is named
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.